Cite
HARVARD Citation
Sato, M. et al. (2021). Predictive value of 3′-deoxy-3′-18F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer. Journal for immunotherapy of cancer. 9 (7), p. . [Online].